the role of bridging and timing in car-t
Published 4 years ago • 59 plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
1:09
the role of allosct in lbcl in the era of car-t
-
1:39
the role of myeloid cells in car-t cell therapy
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:12
expanding the reach of car-t
-
9:54
dr geoffrey lowman discusses t-cell receptor beta sequencing research
-
12:50
3mensio ct pre-case planning: mitral valve-in-ring (mvir) tmvr
-
9:25
mgus diagnosis: a step-by-step approach
-
1:16
car-t treatment journey and the role of the nurse
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:02
the use of car-t cell products in a real-world setting
-
3:31
the role of lymphodepletion in car t-cell therapy: current knowledge & the need for personalization
-
2:53
autohct in dlbcl in the car-t era
-
5:09
the evolving role of nurses in the field of car-t
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
1:52
single-cell and immune sequencing to predict response and resistance to car-t therapy in r/r mm
-
2:45
continuity of care for patients with hematological predispositions to aml
-
1:53
the future of multiple myeloma treatment
-
1:18
the importance of lymphodepletion, an undervalued component of the car-t therapy cycle
-
1:26
the impact of covid-19 on car-t therapy
-
2:01
car-t activity in europe